ArticlePakistan journal of medical sciences2025
Efficacy of medication reconciliation in medication therapy for chronic diseases in elderly patients with coronary atherosclerotic heart disease.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the service model and effect of pharmacist-conducted medication reconciliation (MR) in geriatric patients with coronary atherosclerotic heart disease (coronary heart disease, CHD), so as to provide a reference for grass-roots pharmacists in MR implementation. Methodology: This was a retrospective study. A total of 200 CHD patients admitted to the department of Geriatrics in the First Affiliated Hospital of Hebei North University from January 2023 to July 2024 were randomly divided into a control group (n = 100) and an experimental group (n = 100). The control group was given conventional clinical treatment, while the experimental group was additionally serviced with standardized pharmacist-conducted MR. Both groups were followed up till six months after discharge. PIM use during hospitalization, length of hospital stay, drug costs, incidence of ADRs, patient satisfaction, and medication adherence scores one and six months after discharge were compared between the two groups. Result: Compared with the control group, the experimental group exhibited reduced PIMs, length of hospital stay, drug costs, and incidence of ADRs ( Conclusion: Standardized MR services for CHD patients may be conducive to ensuring rational medication and improving clinical effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.